Novo Nordisk

Novo Nordisk says Lilly’s advertisements use outdated comparisons that omit the recently approved higher dose of Wegovy.

The new business will embed 6,000 industry and engineering experts with customers to build AI systems tied to measurable outcomes, while allowing enterprises to use models from OpenAI, Anthropic, Microsoft and others.

Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026

Delhi High Court pauses Olymviq rollout after Novo Nordisk argues the name is too close to Ozempic just days after semaglutide patent protection expired in India.